194 related articles for article (PubMed ID: 33601910)
1. Global longitudinal assessment of treatment outcomes in recurrent/metastatic nasopharyngeal carcinoma: GLANCE-NPC study.
Ahn MJ; Chirovsky D; Kuyas H; Auclair V; Abounit S; Joo S; Shah R; Yang MH
Future Oncol; 2021 Jun; 17(16):2015-2025. PubMed ID: 33601910
[TBL] [Abstract][Full Text] [Related]
2. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L
Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525
[TBL] [Abstract][Full Text] [Related]
3. Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
Mai HQ; Chen QY; Chen D; Hu C; Yang K; Wen J; Li J; Shi Y; Jin F; Xu R; Pan J; Qu S; Li P; Hu C; Liu YC; Jiang Y; He X; Wang HM; Lim WT; Liao W; He X; Chen X; Wang S; Yuan X; Li Q; Lin X; Jing S; Chen Y; Lu Y; Hsieh CY; Yang MH; Yen CJ; Samol J; Luo X; Wang X; Tang X; Feng H; Yao S; Keegan P; Xu RH
JAMA; 2023 Nov; 330(20):1961-1970. PubMed ID: 38015220
[TBL] [Abstract][Full Text] [Related]
4. The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis.
Zhi-Qiang W; Qi M; Ji-Bin L; Rui Y; You-Ping L; Rui S; Guang-Yuan H; Ming-Yuan C; Yi-Jun H
BMC Cancer; 2019 Nov; 19(1):1122. PubMed ID: 31744469
[TBL] [Abstract][Full Text] [Related]
5. Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.
Lee VHF; Kwong DLW; Lam KO; Lai YC; Li Y; Tong CC; Ho PPY; Chan WL; Wong LS; Leung DKC; Chan SY; Chan FT; Leung TW; Lee AWM
Medicine (Baltimore); 2017 Apr; 96(15):e6518. PubMed ID: 28403082
[TBL] [Abstract][Full Text] [Related]
6. Local and Lymph Node Relapse of Nasopharyngeal Carcinoma: A Single-Center Experience.
Toumi N; Ennouri S; Charfeddine I; Daoud J; Khanfir A
Ear Nose Throat J; 2021 Sep; 100(5_suppl):795S-800S. PubMed ID: 32141322
[TBL] [Abstract][Full Text] [Related]
7. The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012.
Sun XS; Liu SL; Luo MJ; Li XY; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Liang YJ; Yan JJ; Lin DF; Bi MM; Liu Y; Liang YF; Ma J; Tang LQ; Mai HQ
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):581-590. PubMed ID: 31319091
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
[TBL] [Abstract][Full Text] [Related]
9. Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma.
DeRenzo C; Lam C; Rodriguez-Galindo C; Rapkin L; Gottschalk S; Venkatramani R
Pediatr Blood Cancer; 2019 Jan; 66(1):e27469. PubMed ID: 30318742
[TBL] [Abstract][Full Text] [Related]
10. Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma.
Zheng SH; Liu SR; Wang HB; Wei YH; Li H; Wang GN; Huang ZL; Ding SR; Chen C; Tao YL; Li XH; Glorieux C; Huang P; Wu YF; Xia YF
JAMA Netw Open; 2021 Dec; 4(12):e2138444. PubMed ID: 34902036
[TBL] [Abstract][Full Text] [Related]
11. The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 105 cases.
Ma J; Wen ZS; Lin P; Wang X; Xie FY
Chin J Cancer; 2010 Sep; 29(9):787-95. PubMed ID: 20800020
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysis.
Fan Y; Guan W; Huang R; Lin SY; Song Y; Lu S; Kang L; Yang Q; Lang J; Zhang P
Cancer Med; 2020 Dec; 9(24):9315-9325. PubMed ID: 33058559
[TBL] [Abstract][Full Text] [Related]
13. Association of tumor downstaging after neoadjuvant chemotherapy with survival in patients with locally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wang W; Peng S; Wu H; Luo Y; Yuan F; Lin Z; Cheng G; Chen S
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2913-2922. PubMed ID: 34160678
[TBL] [Abstract][Full Text] [Related]
14. Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Grünwald V; Chirovsky D; Cheung WY; Bertolini F; Ahn MJ; Yang MH; Castro G; Berrocal A; Sjoquist K; Kuyas H; Auclair V; Guillaume X; Joo S; Shah R; Harrington K;
Oral Oncol; 2020 Mar; 102():104526. PubMed ID: 31978755
[TBL] [Abstract][Full Text] [Related]
15. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma.
Hong S; Zhang L
Chin J Cancer; 2016 Dec; 35(1):100. PubMed ID: 28007026
[TBL] [Abstract][Full Text] [Related]
17. Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study.
Wang J; Shi M; Hsia Y; Luo S; Zhao L; Xu M; Xiao F; Fu X; Li J; Zhou B; Long X
Radiat Oncol; 2012 Jan; 7():2. PubMed ID: 22233756
[TBL] [Abstract][Full Text] [Related]
18. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis.
Song JH; Wu HG; Keam BS; Hah JH; Ahn YC; Oh D; Noh JM; Park HJ; Lee CG; Keum KC; Cha J; Cho KH; Moon SH; Kim JY; Chung WK; Oh YT; Kim WT; Cho MJ; Kay CS; Kim YS
Cancer Res Treat; 2016 Jul; 48(3):917-27. PubMed ID: 26727716
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
[TBL] [Abstract][Full Text] [Related]
20. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
